xGen Acute Myeloid Leukemia Cancer Panel
The xGen Acute Myeloid Leukemia (AML) Cancer Panel v1.0 comprises 11,731 xGen Lockdown Probes, spanning 1.19 Mb of the human genome, for targeted enrichment of >260 genes associated with AML, to provide more efficient detection of disease-causing mutations.
- Obtain high coverage uniformity with 98% of genomic targets covered at greater than 0.2 x mean coverage
- Detect variations reliably with high reproducibility and increased depth of coverage
- Observe high relevance for AML-related applications due to empirically derived targets
- Enjoy fast turnaround via easy online ordering and next day shipping